Video Experimental Relacionado
Updated: Jul 18, 2026
10:38
Deciphering and Imaging Pathogenesis and Cording of Mycobacterium abscessus in Zebrafish Embryos
Published on: September 9, 2015
Las micolactonas y la enfermedad de Mycobacterium ulcerans
Tjip S van der Werf1, Timothy Stinear, Ymkje Stienstra
1Department of Internal Medicine, Groningen University Medical Centre, Groningen, Netherlands. t.s.van.der.werf@int.azg.nl
Lancet (London, England)
|October 3, 2003
Resumen
La úlcera de Buruli, causada por Mycobacterium ulcerans, conduce a lesiones necróticas. Los ensayos clínicos futuros probarán prometedores fármacos antimicobacterianos, ofreciendo potencialmente alternativas a la cirugía para esta enfermedad tropical descuidada.
Área de la Ciencia:
- Enfermedades infecciosas Enfermedades infecciosas.
- La Medicina Tropical es una medicina tropical.
- Microbiología Microbiología.
Sus antecedentes:
- La infección por Mycobacterium ulcerans, conocida como úlcera de Buruli, causa daño tisular significativo y está aumentando en África Occidental.
- El tratamiento actual se basa principalmente en la cirugía, con datos limitados de ensayos clínicos que respaldan los fármacos antimicobacterianos.
- La toxina micolactona secretada por M. ulcerans es la causa principal de la destrucción de los tejidos.
Objetivo del estudio:
- Revisar la comprensión actual de la úlcera de Buruli, incluyendo su epidemiología, patogénesis y desafíos de tratamiento.
- Para resaltar la necesidad de ensayos clínicos bien diseñados para evaluar la eficacia del fármaco antimicobacteriano.
- Explorar posibles direcciones futuras de investigación, incluido el desarrollo de vacunas y nuevos objetivos de medicamentos.
Principales métodos:
- Revisión de la literatura de los estudios existentes sobre la úlcera de Buruli.
- Análisis de datos epidemiológicos y resultados del tratamiento.
- Exploración de la información genómica para posibles objetivos terapéuticos.
Principales resultados:
- La prevalencia de la úlcera de Buruli está aumentando en África Occidental, con una presentación tardía a menudo debido a las creencias culturales sobre la enfermedad y el tratamiento.
- La intervención quirúrgica sigue siendo el pilar del tratamiento, pero la renuencia de los pacientes se debe a la percepción de ineficacia y costo.
- Los conocimientos genómicos sobre M. ulcerans ofrecen vías para desarrollar nuevas vacunas y objetivos farmacológicos, como la inhibición de la síntesis de micolactona.
Conclusiones:
- Hay una necesidad urgente de ensayos clínicos robustos para evaluar la eficacia de los fármacos antimicobacterianos para la úlcera de Buruli.
- Comprender las creencias de los pacientes y mejorar el acceso a un tratamiento efectivo son cruciales para el manejo de la enfermedad.
- Aprovechar los datos genómicos es prometedor para estrategias innovadoras contra la úlcera de Buruli.
Videos de Conceptos Relacionados
01:17Chronic Bowel Disorders: Introduction
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
01:28Pulmonary Tuberculosis II
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
01:31Pulmonary Tuberculosis III
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
01:23Tuberculosis
Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...
01:27Peptic Ulcer
Peptic ulcers are erosive lesions of the gastric or duodenal lining, most commonly caused by Helicobacter pylori infection. This Gram-negative, helical bacterium has adapted to survive the stomach’s acidic environment by producing urease, which converts urea into ammonia and carbon dioxide. The ammonia neutralizes gastric acid in the bacterium’s immediate environment, allowing colonization of the gastric mucosa. H. pylori attaches to mucus-secreting epithelial cells, penetrates the mucus...